From trash to leucocytes: What are we filtering and why?

Journal of Extra-Corporeal Technology

Volumn 38, Issue 1, 2006, Pages 58-63

  Mitchell, Simon J ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

ARTERIAL BLOOD; BLOOD FILTER; BLOOD FILTRATION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONFERENCE PAPER; HOSPITALIZATION; HUMAN; INFLAMMATION; LEUKOCYTE; MICROEMBOLISM; OUTCOME ASSESSMENT; PERICARDIUM; SUCTION; CORONARY ARTERY BYPASS GRAFT; HEMOFILTRATION; INSTRUMENTATION; METHODOLOGY; OXYGENATOR; REVIEW; TREATMENT OUTCOME;

CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; HEMOFILTRATION; HUMANS; INFLAMMATION; LEUKOCYTES; OXYGENATORS, MEMBRANE; TREATMENT OUTCOME;

EID: 33744986254     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Gu YJ, de Vries AJ, Boonstra PW, Van Oeveren W. Mechanism and strategy of leukocyte depletion during cardiopulmonary bypass surgery. In: Matheis G, Moritz A, Scholz M, eds. Leukocyte Depletion in Cardiac Surgery and Cardiology. Basel: Karger Publishers; 2002;78-88.
2. Hill JD, Osborne JJ, Swank RL, Aguilar MJ, Gerbode F, deLanerolle P. Experience using a new dacron wool filter during extracorporeal circulation. Arch Surg. 1970;101:649-52.
3. Patterson RH, Kessler J, Bergland RM. A filter to prevent cerebral damage during experimental cardiopulmonary bypass. Surg Gyn Obstet. 1971;132:71-4.
4. Whitaker DC, Stygall JA, Newman SP, Harrison MJG. The use of leucocyte-depleting and conventional arterial line filters in cardiac surgery: a systematic review of clinical studies. Perfusion. 2001;16:433-46.
5. Kurusz M, Schneider B, Brown J, Conti V. Filtration during open heart surgery; devices techniques, opinions and complications. Proc Am Acad Cardiovasc Perf. 1983;4:123-9.
6. Mejak BL Stammers A Rauch E. Vang S, Viessman T. A retrospective study on perfusion incidents and safety devices. Perfusion. 2000;15:51-61.
7. Kong R, Stygall J, Aveling W, Pugsley W, Harrison M, Newman S. Protection and anaesthesia for adult cardiac surgery in the UK and Ireland. Presented at the Meeting of the Association of Cardiothoracic Anaesthetists. November 1998. Cited in Whitaker DC et al. Perfusion 2001;16:433-46.
8. Loop FD, Szabo J, Rowlinson RD, Urbanek K. Events related to microembolism during extra-corporeal perfusion in man: effectiveness of in-line filtration recorded by ultrasound. Ann Thorac Surg. 1976;21:412-20.
9. Mitchell SJ, Willcox T, Gorman DF. Bubbles generation and venous air filtration by hard-shell venous reservoirs: a comparative study. Perfusion. 1997;12:325-33.
10. Padayachee TS, Parsons S, Theobold R, Gosling RG, Deverall PB. The effect of arterial filtration on reduction of gaseous microemboli in the middle cerebral artery during cardiopulmonary bypass. Ann Thorac Surg. 1988;45:647-9.
11. Barbut D, Hinton RB, Szatrowski TP, et al. Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke. 1994;25:2398-402.
12. Clark RE, Brillman J, Davis DA, Lovell MR, Price TR, Magovern GJ. Microemboli during coronary artery bypass grafting, Genesis and effect on outcome. J Thorac Cardiovasc Surg. 1995;109:249-58.
13. Stump DA, Rogers AT, Hammon JW, Newman SP. Cerebral emboli and cognitive outcome after cardiac surgery. J Cardiothorac Vasc Anesth. 1996;10:113-9.
14. Arrowsmith JE, Stygall J, Timberlake N, et al. Correlation between middle cerebral artery microemboli and neuropsychological deficits following cardiopulmonary bypass with a membrane oxygenator. Ann Thorac Surg. 1997:64:924.
15. Stump DA, Fedorko L, Brooker R, Hilbawi H, Kon NA, Hammon JW. Biochemical markers of brain injury, embolic load, bypass time and neurobehavioural deficits after CABG surgery: is there a relationship. Ann Thorac Surg. 1997;64:920.
16. Hammon JW, Stump DA, Kon ND, et al. Risk factors and solutions for the development of neurobehavioral changes after coronary artery bypass grafting. Ann Thorac Surg. 1997;63:1613-8.
17. Fearn SJ, Pole R, Wesnes K, Faragher EB, Hooper TL, McCollum CN. Cerebral injury during cardiopulmonary bypass: emboli impair memory. J Thorac Cardiovasc Surg. 2001;121:1150-60.
18. Aberg T, Kihlgren M. Cerebral protection during open heart surgery. Thorax. 1977;32:525-33.
19. Garvey JW, Willner A, Wolpowitz A et al. The effect of arterial filtration during open heart surgery on cerebral function. Circulation 1983;68:125-8.
20. Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke. 1994;25:1393-9.
21. Whitaker DC, Newman SP, Stygall J, Hoope-Wynn C, Harrison MJG, Walesby RK. The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardio-thorac Surg 2004;267-74.
22. Taggart DP, Bhattacharya K, Meston N, et al. Serum S-100 protein concentration after cardiac surgery: a randomized trial of arterial line filtration. Eur J Cardiothorac Surg. 1997;11:645-49.
23. de Vroege R, te Meerman F, Eijsman L, Wildevuur WR, Wildevuur ChRH, van Oeveren W. Induction and detection of disturbed homeostasis in cardiopulmonary bypass. Perfusion. 2004;19:267-76.
24. Rubens FD, Mesana T. The inflammatory response to cardiopulmonary bypass: a therapeutic overview. Perfusion. 2004;19:S5-S12.
25. Zamboni WA. The microcirculation and ischemia-reperfusion: basic mechanisms of hyperbaric oxygen. In: Kindwall E, Whelan HT, eds. Hyperbaric Medicine Practice. Flagstaff AZ: Best Publishers; 1999; 779-94.
26. Smit JJ, de Vries AJ, Gu YJ, van Oeveren W. Filtration of activated granulocytes during cardiopulmonary bypass surgery: A morphological and immunological study to characterize the trapped leukocytes. J Lab Clin Med. 2000;135:238-46.
27. Matheis G, Scholz M, Simon A, Henrich D, Wimmer-Greinecker G, Moritz A. Timing of leukocyte filtration during cardiopulmonary bypass. Perfusion. 2001;16(supp):31-7.
28. Patel AN, Sutton SW, Livingston S, et al. Clinical benefits of leukocyte filtration during valve surgery. Am J Surg. 2003;186:636-40.
29. Chen YF, Tsai WC, Lin CC, et al. Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg. 2004;78:634-42.
30. Garner JR, Stroud RE, Finklea L, Ikononmidis JS, Dorman BH, Spinale FG. The effects of leukocyte reduction on matrix metalloproteinase release in cardiopulmonary bypass. J Extra Corpor Technol. 2004;36:185-90.
31. Sheppard SV, Gibbs RV, Smith DC. Does the use of leucocyte depletion during cardiopulmonary bypass affect exhaled nitric oxide production? Perfusion. 2004;19:7-10.
32. Sahlman A, Ahonen J, Salo JA, Ramo OJ. No impact of a leucocyte depleting arterial line filter on patient recovery after cardiopulmonary bypass. Acta Anasthesiol Scand. 2001;45:558-63.
33. Matheis G, Scholz M, Gerber J, Abdel-Rahman U, Wimmer-Greinecker G, Moritz A. Leukocyge filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury. Perfusion. 2001;16:43-9.
34. Baksaas ST, Flom-Halvorsen HI, Ovrum E, et al. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion. 1999;14:107-17.
35. deVries A, Gu YJ, Post WJ, et al. Leucocyte depletion during cardiac surgery: a comparison of different filtration strategies. Perfusion. 2003;18:31-8.
36. Stefanou DC, Gourlay T, Asimakopoulos G, Tayor KM. Leucodepletion during cardiopulmonary bypass reduces blood transfusion and crystalloid requirements. Perfusion. 2001;16:51-8.
37. Mair P, Hoermann C, Mair J, Margreitter J, Puschendorf B, Balogh D. Effects of a leucocyte depleting arterial line filter on perioperative proteolytic enzyme and oxygen free radical release in patients undergoing aortocoronary bypass surgery. Acta Anesthesiol Scand. 1999;43:452-7.
38. Baksaas ST, Videm V, Mollnes TE, et al. Leucocyte filtration curing cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets. Perfusion. 1998;13:429-36.
39. Mihaljevic T, Tonz M, von Segesser LK, et al. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study. J Thorac Cardiovasc Surg. 1995;109:1138-45.
40. Scholz M, Simon A, Matheis G, et al. Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res. 2002;51:363-8.
41. Fabbri A, Manfredi J, Piccin C, et al. Systemic leukocyte filtration during cardiopulmonary bypass. Perfusion. 2001;16:1-8.
42. Di Salvo C, Loucca LL, Pattichis K, Hooper J, Walesby RK. Does activated neutrophil depletion on bypass by leucocyte filtration reduce myocardial damage. J Cardiovasc Surg. 1996;37(supp 6):93-100.
43. Hachida M, Hanayama N, Okamura T, et al. The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass. ASAIO J. 1995;41:M291-4.
44. Sheppard SV, Gibbs RV, Smith DC. Does leucocyte depletion during cardiopulmonary bypass improve oxygenation indices in patients with mild lung dysfunction? Br j Anaesth. 2004;93:789-92.
45. Johnson D, Thomson D, Mycyk T, Burbridge B, Mayers I. Depletion of neutrophils by filter during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status. Chest. 1995;107:1253-9.
46. Karaiskos TE, Palatianos GM, Triantafillou CD, et al. Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease. Ann Thorac Surg. 2004;78:1339-44.
47. Olivencia-Yurvati AH, Ferrara CA, Tierney N, Wallace N, Mallet RT. Strategic leuckocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopumonary bypass. Perfusion. 2003;18:23-31.
48. Gott JP, Cooper WA, Schmidt FE, et al. Modifying risk for extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg. 1998;66:747-54.
49. Heggie A, Corder J, Crichton P, Hesford J, Bingham H, Jeffries S. Clinical evaluation of the new Pall leucocute-depleting blood cardioplegia filter (BC1). Perfusion. 1998;13:17-25.
50. Roth M, Kraus B, Scheffold T, Reuthebuch O, Klovekorn W, Bauer E. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg. 2000;120:642-50.
51. Palatianos GM, Balentine G, Papadakis EG, et al. Neutrophil depletion reduces myocardial reperfusion morbidity. Ann Thorac Surg. 2004;77:956-61.
52. Suzuki I, Ogoshi N, Chiba M, Komatsu T, Moizumi Y. Clinical evaluation of a leucocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery. Perfusion. 1998;13:205-10.
53. Sawa Y, Tniguchi K, Kadoba K, et al. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation. 1996;93:1640-6.
54. Ichihara T, Yasuura K, Maseki T, et al. The effects of using a leukocyte removal filter during cold blood cardioplegia. Surg Today. 1994;24:966-72.
55. Sawa Y, Matsuda H, Shimazaki Y, et al. Evaluation of leucocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108:1125-31.
56. Pearl JM, Drinkwater DC, Laks H, Capouya ER, Gates RN. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized double blind clinical trial. J Heart Lung Transplant. 1992;11:1082-92.
57. Browning P, Pullen M, Jackson M, Rashid A. Leucocyte depleted cardioplegia does not reduce reperfusion injury in hypothermic coronary artery bypass surgery. Perfusion. 1999;14:371-7.
58. Martin J, Krause M, Benk C, Lutter G, Siegenthaler M, Beyersdorf F. Blood cardioplegia filtration. Perfusion. 2003;18:75-80.
59. Ortolano GA, Aldea GS, Lilly K, et al. A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of anti-inflammatory effects. Perfusion. 2002;17:53-62.
60. Brooker RF, Brown WR, Moody DM, et al. Cardiopulmonary suction: a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg. 1998;65:1651-5.
61. Brown WR, Moody DM, Challa VR. Cerebral fat embolism from cardiopulmonary bypass. J Neuropathol Exp Neurol. 1999;58:109-19.
62. Appelblad M, Engstrom G. Fat contamination of pericardial suction blood and its influence on in vitro capillary pore flow properties in patients undergoing routine coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2002;123:381-3.
63. Svenmarker S, Engstrom KG, Karlsson T, Jansson E, Lindholm R, Aberg T. Influence of pericardial suction blood retransfusion on memory function and release of protein S100B. Perfusion. 2004;19:337-43.
64. Jewel AE, Akowuah EF, Survarna SK, et al. A prospective randomized comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg. 2003;23:633-6.
65. Kincaid EH, Jones TJ, Stump DA, et al. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization. Ann Thorac Surg. 2000;70:1296-300.
66. Kaza AK, Cope JT, Fiser SM. Elimination of fat microemboli during cardiopulmonary bypass. Ann Thorac Surg. 2003;75:555-9.
67. Engstrom KG. The embolic potential of liquid fat in pericardial suction blood, and its elimination. Perfusion. 2003;18:69-74.
68. Abdel-Rahman U, Ozaslan F, Risteski PS, et al. Initial experience with a minimized extracorporeal bypass system: is there a clinical benefit? Ann Thorac Surg. 2005;80:238-43.